Type I interferon response to extracellular bacteria in the airway epithelium

Trends in Immunology

Volumn 32, Issue 12, 2011, Pages 582-588

  Parker, Dane ^a   Prince, Alice ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA CATENIN; BETA INTERFERON; CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 6; LIPID BINDING PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2;

BACTERIAL INFECTION; EXTRACELLULAR BACTERIA; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; EPITHELIUM; EXTRACELLULAR SPACE; HUMANS; INTERFERON TYPE I; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION;

EID: 81355127453     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2011.09.003     Document Type: Review

References (89)

1. Monroe K.M., et al. Induction of type I interferons by bacteria. Cell Microbiol. 2010, 12:881-890.
2. Woodward J.J., et al. c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science 2010, 328:1703-1705.
3. Trinchieri G. Type I interferon: friend or foe?. J. Exp. Med. 2010, 207:2053-2063.
4. Decker T., et al. The yin and yang of type I interferon activity in bacterial infection. Nat. Rev. Immunol. 2005, 5:675-687.
5. Muller U., et al. Functional role of type I and type II interferons in antiviral defense. Science 1994, 264:1918-1921.
6. Staeheli P., et al. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 1988, 8:4518-4523.
7. Debes G.F., et al. Chemotactic responses of IL-4-, IL-10-, and IFN-gamma-producing CD4+ T cells depend on tissue origin and microbial stimulus. J. Immunol. 2006, 176:557-566.
8. Der S.D., et al. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:15623-15628.
9. Kagan J.C., et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 2008, 9:361-368.
10. Hacker H., et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006, 439:204-207.
11. Schindler C., Plumlee C. Inteferons pen the JAK-STAT pathway. Semin. Cell Dev. Biol. 2008, 19:311-318.
12. Benveniste E.N., Qin H. Type I interferons as anti-inflammatory mediators. Sci. STKE 2007, 2007:pe70.
13. Kawai T., et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 2001, 167:5887-5894.
14. Yu H., et al. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis. Infect. Immun. 2000, 68:2142-2147.
15. Weber S.E., et al. CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice. J. Immunol. 2011, 186:432-442.
16. Satorres S.E., et al. IFN-gamma plays a detrimental role in murine defense against nasal colonization of Staphylococcus aureus. Immunol. Lett. 2009, 123:185-188.
17. Mordstein M., et al. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 2008, 4:e1000151.
18. Blasius A.L., Beutler B. Intracellular toll-like receptors. Immunity 2010, 32:305-315.
19. Parker D., Prince A. Innate immunity in the respiratory epithelium. Am. J. Respir. Cell Mol. Biol. 2011, 10.1165/rcmb.2011-0011RT.
20. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
21. Lenardo M.J., et al. The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 1989, 57:287-294.
22. Sato M., et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000, 13:539-548.
23. Fitzgerald K.A., et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003, 4:491-496.
24. Ishikawa H., et al. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461:788-792.
25. Alexopoulou L., et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
26. Poltorak A., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
27. Diebold S.S., et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
28. Heil F., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
29. Hemmi H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
30. Takaoka A., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448:501-505.
31. Unterholzner L., et al. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 2010, 11:997-1004.
32. Ablasser A., et al. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 2009, 10:1065-1072.
33. Chiu Y.H., et al. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138:576-591.
34. Yang P., et al. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat. Immunol. 2010, 11:487-494.
35. Pandey A.K., et al. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog. 2009, 5:e1000500.
36. Sabbah A., et al. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 2009, 10:1073-1080.
37. Leber J.H., et al. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog. 2008, 4:e6.
38. Franks T.J., et al. Resident cellular components of the human lung: current knowledge and goals for research on cell phenotyping and function. Proc. Am. Thorac. Soc. 2008, 5:763-766.
39. Mayer A.K., et al. Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J. Immunol. 2007, 178:3134-3142.
40. Muir A., et al. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 2004, 30:777-783.
41. Berube J., et al. Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/TLR2, TLR3 or NOD1 activated human airway epithelial cells. Cell Signal. 2009, 21:448-456.
42. Platz J., et al. Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J. Immunol. 2004, 173:1219-1223.
43. Shornick L.P., et al. Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection. J. Immunol. 2008, 180:3319-3328.
44. Xing Z., et al. Host immune and apoptotic responses to avian influenza virus H9N2 in human tracheobronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 2010, 44:24-33.
45. Wang Q., et al. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J. Immunol. 2009, 183:6989-6997.
46. Ritter M., et al. Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR3 ligand poly(I:C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory response. J. Inflamm. (Lond) 2005, 2:16.
47. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005, 23:275-306.
48. Martin F.J., et al. Participation of CD11c+ leukocytes in the host response to MRSA infection of the lung. Infect. Immun. 2011, 79:1898-1904.
49. Zhang Z., et al. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J. Clin. Invest. 2009, 119:1899-1909.
50. Kooguchi K., et al. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect. Immun. 1998, 66:3164-3169.
51. Cheung D.O., et al. Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa. Infect. Immun. 2000, 68:4585-4592.
52. Rate A., et al. Airway epithelial cells regulate the functional phenotype of locally differentiating dendritic cells: implications for the pathogenesis of infectious and allergic airway disease. J. Immunol. 2009, 182:72-83.
53. Hammad H., Lambrecht B.N. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat. Rev. Immunol. 2008, 8:193-204.
54. Kadioglu A., et al. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol. 2008, 6:288-301.
55. Chetty C., Kreger A. Role of autolysin in generating the pneumococcal purpura-producing principle. Infect. Immun. 1981, 31:339-344.
56. Movitz J. Formation of extracellular protein A by Staphylococcus aureus. Eur. J. Biochem. 1976, 68:291-299.
57. Gomez M.I., et al. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat. Med. 2004, 10:842-848.
58. Joyce E.A., et al. Streptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferon-induced gene expression. BMC Genomics 2009, 10:404.
59. Parker D., et al. Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. MBio 2011, 2. e00016-00011.
60. Weigent D.A., et al. Role of interferon in streptococcal infection in the mouse. Microb. Pathog. 1986, 1:399-407.
61. Shahangian A., et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J. Clin. Invest. 2009, 119:1910-1920.
62. Parker D., et al. Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells. Am. J. Respir. Cell Mol. Biol. 2011.
63. Skerrett S.J., et al. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 292:L312-L322.
64. Ramphal R., et al. TLRs 2 and 4 are not involved in hypersusceptibility to acute Pseudomonas aeruginosa lung infections. J. Immunol. 2005, 175:3927-3934.
65. Faure K., et al. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respir. Res. 2004, 5:1.
66. Power M.R., et al. A role of Toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta in the host response to Pseudomonas aeruginosa lung infection in mice. J. Immunol. 2007, 178:3170-3176.
67. Carrigan S.O., et al. IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice. J. Immunol. 2010, 185:3602-3609.
68. Meylan E., et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat. Immunol. 2004, 5:503-507.
69. Ernst R.K., et al. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 1999, 286:1561-1565.
70. Cigana C., et al. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection. PLoS ONE 2009, 4:e8439.
71. Martin F.J., et al. Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J. Clin. Invest. 2009, 119:1931-1939.
72. Klevens R.M., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
73. Hageman J.C., et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-4 influenza season. Emerg. Infect. Dis. 2006, 12:894-899.
74. Huys L., et al. Type I interferon drives tumor necrosis factor-induced lethal shock. J. Exp. Med. 2009, 206:1873-1882.
75. Manicone A.M., et al. CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung. Exp. Lung Res. 2008, 34:391-407.
76. Lee M.H., et al. A postinfluenza model of Staphylococcus aureus pneumonia. J. Infect. Dis. 2010, 201:508-515.
77. Kudva A., et al. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J. Immunol. 2011, 186:1666-1674.
78. Hirano T., et al. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000, 19:2548-2556.
79. Schmitz F., et al. Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur. J. Immunol. 2007, 37:315-327.
80. Dietrich N., et al. Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments. PLoS ONE 2010, 5:e10250.
81. Liljeroos M., et al. Bacterial ligand of TLR2 signals Stat activation via induction of IRF1/2 and interferon-alpha production. Cell Signal. 2008, 20:1873-1881.
82. Charrel-Dennis M., et al. TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe 2008, 4:543-554.
83. Bukholm G., et al. Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice. Infect. Immun. 1984, 45:62-66.
84. Carrero J.A., et al. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J. Exp. Med. 2004, 200:535-540.
85. Gratz N., et al. Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection. PLoS Pathog. 2011, 7:e1001345.
86. Mancuso G., et al. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat. Immunol. 2009, 10:587-594.
87. Deshmukh S.D., et al. Macrophages recognize streptococci through bacterial single-stranded RNA. EMBO Rep. 2011, 12:71-76.
88. Mancuso G., et al. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J. Immunol. 2007, 178:3126-3133.
89. Leichtle A., et al. The toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery. BMC Immunol. 2009, 10:45.